US Patent Issued to The University of Hong Kong on March 31 for "PEGylated synthetic KL4 peptide, compositions and methods thereof" (Chinese Inventors)

ALEXANDRIA, Va., March 31 -- United States Patent no. 12,589,161, issued on March 31, was assigned to The University of Hong Kong (Hong Kong).

"PEGylated synthetic KL4 peptide, compositions and methods thereof" was invented by Ka Wing Lam (Hong Kong), Yingshan Qiu (Hong Kong) and Yee Tak Chow (Hong Kong).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are relating to pulmonary delivery of mRNA as inhaled dry powder formulation and compositions comprising the mRNA; also provided are methods of using and making the composition."

The patent was filed on July 10, 2020, under Application No. 17/625,212.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/ne...